Search
for
Sort by
Research 31–60 of 287
- The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature
- Redefining hormone resistance in prostate cancer
- Role of Polycystic Ovary Syndrome in Increasing Susceptibility to COVID-19: A Biochemical and Psychological Approach
- Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity
- Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19
- Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
- The immune response to COVID‐19: Does sex matter?
- Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19
- Do Anti-androgens Have Potential as Therapeutics for COVID-19?
- Ex vivo detection of SARS CoV 2 spike protein in human hair follicles and potential link to telogen effluvium
- Trapa bispinosa Roxb. Pericarp Extract Exerts 5α-Reductase Inhibitory Activity in Castrated Benign Prostatic Hyperplasia Model Mice
- Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia
- ВЛИЯНИЕ АНДРОГЕННОГО СТАТУСА И АНТИАНДРОГЕННОЙ ТЕРАПИИ НА ТЕЧЕНИЕ COVID-19 У МУЖЧИН
- The role of testosterone in SARS-CoV-2 infection
- Genetic and hormonal influence on SARS-CoV-2-infection susceptibility
- From bedside to bench: regulation of host factors in SARS-CoV-2 infection
- ACE1 rs1799752 polymorphism is not associated with long-COVID symptomatology in previously hospitalized COVID-19 survivors
- Matriptase Expression and Zymogen Activation in Human Pilosebaceous Unit
- Perspective Chapter: Repurposing Natural Products to Target COVID-19 – Molecular Targets and New Avenues for Drug Discovery
- Gender Differences in Response to COVID-19 Infection and Vaccination
- Antiandrogens as Therapies for COVID-19: A Systematic Review
- The impact of SARS-CoV-2 and COVID-19 on male reproduction and men’s health
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- Alopecia and grey hair are associated with COVID‐19 Severity
- Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity
- COVID‐19, androgens, and androgenic alopecia
- Androgens in SARS-CoV-2 Coronavirus Infections
- Comment on “Androgens and women: COVID‐19 outcomes in women with acne vulgaris, polycystic ovarian syndrome, and hirsutism”
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia